Clinical effectiveness and safety of once-weekly GLP-1 receptor agonist dulaglutide as add-on to metformin or metformin plus insulin secretagogues in obesity and type 2 diabetes
Outside the US it is supplied as a research-grade peptide and is not approved for human use by any major regulator
The licensed pharmacist and/or licensed physician maintains the responsibility to ensure compliance with Section 503A of the Food, Drug and Cosmetic Act, including the requirement that a compound be dispensed pursuant to a valid prescription, from a licensed prescriber, for an identified individual patient
Type 2 diabetes is generally (though not exclusively) caused by poor lifestyle and excess body fat, especially that around the mid-section
Blood pressure showed a non-significant trend toward reduction in aortic stiffness, a finding that has not been replicated at scale
Most men waited far too long before asking about low desire